References

Samaranayake L. Essential Microbiology for Dentistry, 5th edn. London: Elsevier; 2018
Treanor J. Influenza vaccine – outmaneuvering antigenic shift and drift. N Engl J Med. 2004; 350:218-220
Couch RB, Atmar RL, Franco LM Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis. 2013; 207:974-981 https://doi.org/10.1093/infdis/jis935
Parrish CR, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol. 2005; 59:553-586 https://doi.org/10.1146/annurev.micro.59.030804.121059
Klempner MS, Shapiro DS. Crossing the species barrier – one small step to man, one giant leap to mankind. N Engl J Med. 2004; 350:1171-1172 https://doi.org/10.1056/NEJMp048039
Basu A, Sarkar A, Maulik U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci Rep. 2020; 10 https://doi.org/10.1038/s41598-020-74715-4
The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells. 2020. https://tinyurl.com/yty7c2dm (accessed March 2021)
Daly JL, Simonetti B, Klein K Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020; 370:861-865 https://doi.org/10.1126/science.abd3072
van Dorp L, Richard D, Tan CCS No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020; 11 https://doi.org/10.1038/s41467-020-19818-2
Sanjuán R, Domingo-Calap P. Mechanisms of viral mutation. Cell Mol Life Sci. 2016; 73:4433-4448 https://doi.org/10.1007/s00018-016-2299-6
Zhu N, Zhang D, Wang W A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727-733 https://doi.org/10.1056/NEJMoa2001017
Office for National Statistics. Coronavirus (COVID-19) roundup. 2021. https://tinyurl.com/aakpypxs (accessed March 2021)
SARS-CoV-2 variant under investigation 202012/01 has more than twofold replicative advantage. 2021. https://tinyurl.com/z3umnx43 (accessed March 2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. 2021. https://tinyurl.com/4xabfy9c (accessed March 2021)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 VOC 202012/01 (B.1.1.7). Lancet preprint. 2021. https://tinyurl.com/73x4ha8y (accessed March 2021)
Tegally H, Wilkinson E, Lessells RJ Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat Med. 2021; https://doi.org/10.1038/s41591-021-01255-3
SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma. 2021. https://tinyurl.com/2n7cs39w (accessed March 2021)
Centers for Disease Control. Emerging SARS-CoV-2 variants. 2021. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html (accessed March 2021)
Samaranayake LP, Anil S. Understanding COVID-19 vaccines, and immunity. Dent Update. 2021; 48:156-159

SARS-CoV-2 Variants and COVID-19: An Overview

From Volume 48, Issue 3, March 2021 | Pages 235-238

Authors

Lakshman Samaranayake

DSc, DDS, FRCPath, FHKCPath, FDS RCS(Edin), FRACDS, FDS RCPS

Professor Emeritus, and Immediate-past Dean, Faculty of Dentistry, University of Hong Kong

Articles by Lakshman Samaranayake

Email Lakshman Samaranayake

Kausar Sadia Fakhruddin

BDS, MSc, Lecturer

Lecturer, Departments of Preventive and Restorative Dentistry, College of Dental Medicine, University of Sharjah, UAE

Articles by Kausar Sadia Fakhruddin

Abstract

All viruses, including coronaviruses, change over time. This leads to multiple progenies of viral strains, with virulence traits that are unlike those of their parents. This article provides an overview of how viral variants emerge, and the signs and symptoms of variant-related COVID-19.

Article

‘In the struggle for survival, the fittest win out at the expense of their rivals as they succeed in adapting themselves best to their environment.’

Owing to their constant replicative cycle, all viruses, including coronaviruses, change over time. This leads to multiple progenies of viral strains, with virulence traits that are unlike those of their parents. Since the arrival of the parental strain of SARS-CoV-2 from China over a year ago, it too has followed the natural Darwinian pathway of ‘survival of the fittest,’ leading to the production of three major strains/variants, currently in global circulation. These, the UK (Kent), the South African, and the Brazilian variants, with different geographical origins and sharing some of the mutations, are highly transmissible and equally deadly. Whether the variants are vaccine resistant is yet another major concern. Here, we provide an overview of how viral variants emerge and the signs and symptoms of variant-related COVID-19. The elucidation of the similarities and differences between SARS-CoV-2 variants should be helpful in developing future strategies to combat the pandemic.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available